Taio Naniwa

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

Journal of bone and mineral metabolism

International journal of rheumatic diseases

Modern rheumatology case reports

Modern rheumatology

Nagoya City University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nagoya City University

Japan

Associate professor :: Dept of Respiratory Medicine, Allergy and Clinical Immunology

Publications

Shuntaro Isogai, Masayuki Mizuno, Koji Uehara, Kenji Okita, Taio Naniwa
Case report: Additional use of hydroxychloroquine in treatment-resistant recurrent cerebral infarctions with antiphospholipid antibody syndrome. International journal of rheumatic diseases 27 (2) (2024)
Shin-Ya Tamechika, Shin-Ichiro Ohmura, Shinji Maeda, Taio Naniwa
Efficacy of denosumab on bisphosphonate-treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids. Journal of bone and mineral metabolism 41 (2) (2022)
Taio Naniwa, Toru Yamabe, Shin-Ichiro Ohmura, Koji Uehara, Shin-Ya Tamechika, Shinji Maeda, Shuntaro Isogai, Junichi Wada
Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment. International journal of rheumatic diseases 25 (9) (2022)
Shin-Ya Tamechika, Shin-Ichiro Ohmura, Shinji Maeda, Taio Naniwa
Efficacy of denosumab on bisphosphonate-treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids. Journal of bone and mineral metabolism (2022)
Shin-Ya Tamechika, Shin-Ichiro Ohmura, Shinji Maeda, Taio Naniwa
Efficacy of denosumab on bisphosphonate-treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids. Journal of bone and mineral metabolism 41 (2) (2022)
Shin-Ichiro Ohmura, Shin-Ya Tamechika, Toshiaki Miyamoto, Kenjiro Kunieda, Taio Naniwa
Impact of dysphagia and its severity on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathies other than inclusion body myositis. International journal of rheumatic diseases 25 (8) (2022)
Shin-Ya Tamechika, Shin-Ichiro Ohmura, Shinji Maeda, Taio Naniwa
Efficacy of denosumab on bisphosphonate-treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids. Journal of bone and mineral metabolism 41 (2) (2022)
Toru Yamabe, Shin-Ichiro Ohmura, Koji Uehara, Taio Naniwa
Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study. Modern rheumatology (2021)
Taio Naniwa, Koji Uehara, Toru Yamabe, Shin-Ichiro Ohmura
Reintroduction of tocilizumab elicited macrophage activation syndrome in a patient with adult-onset Still's disease with a previous successful tocilizumab treatment. Modern rheumatology case reports 5 (2) (2021)
Shin-Ichiro Ohmura, Koji Uehara, Toru Yamabe, Shinya Tamechika, Shinji Maeda, Taio Naniwa
Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide. Modern rheumatology case reports 4 (2) (2020)
Shin-Ichiro Ohmura, Toru Yamabe, Taio Naniwa
Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies. Modern rheumatology case reports 5 (1) (2020)
Taio Naniwa, Shiho Iwagaitsu, Mikiko Kajiura
Successful cessation of tumor necrosis factor inhibitor treatment in rheumatoid arthritis patients and potential predictors for early flare: An observational study in routine clinical care. Modern rheumatology 30 (6) (2020)
Taio Naniwa, Shiho Iwagaitsu, Mikiko Kajiura
Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors. International journal of rheumatic diseases 21 (3) (2018)
Shiho Iwagaitsu, Taio Naniwa
Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab. Case reports in rheumatology 2017 (2017)

Taio Naniwa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Taio Naniwa